What is RSV, and why does it matter?

Respiratory syncytial virus (RSV) is a common germ that infects the lungs and breathing passages. Most children have had RSV by age two, and it can cause cold-like symptoms in healthy adults. However, RSV can lead to serious lung infections—such as bronchiolitis and pneumonia—in:

• Infants, especially those born prematurely
• Older adults (60 years and up)
• People with weakened immune systems or certain chronic health issues

Understanding what is RSV vaccine and how it works helps protect these at-risk groups and reduce hospitalizations.

---

What is RSV vaccine?

An RSV vaccine is a preventive medicine designed to train the immune system to recognize and fight RSV before it causes serious illness. Unlike treatments given after infection, vaccines are administered ahead of RSV season or at key life stages (e.g., late pregnancy, older adulthood) to build protective antibodies.

Key goals of RSV vaccination:

• Reduce severe lung infections
• Lower hospital and intensive-care admissions
• Decrease RSV-related complications and deaths

---

Who needs the RSV vaccine?

Current public health recommendations focus on:

• Infants and young children: A single dose of a long-acting monoclonal antibody may be offered to newborns and infants during RSV season.
• Pregnant people: A maternal RSV vaccine in the late second or third trimester passes protective antibodies to the baby.
• Older adults (≥ 60 years): Approved RSV vaccines boost waning immune defenses and help prevent severe RSV disease.

Talk with your health care provider to see if RSV vaccination or prophylaxis fits your situation.

---

Types of RSV vaccines and monoclonal antibodies

1. Monoclonal antibody (mAb) prophylaxis for infants

   • Example: nirsevimab (brand name Beyfortus)
   • Given as a single injection before or early in RSV season
   • Designed to last through the peak months of RSV circulation

2. Maternal RSV vaccine

   • Example: Pfizer’s Abrysvo maternal formulation
   • Administered between weeks 32–36 of pregnancy
   • Antibodies transfer to the fetus, protecting the newborn for the first months of life

3. Adult RSV vaccines

   • Example: GSK’s Arexvy and Pfizer’s Abrysvo adult formulation
   • Recommended for adults 60 years and older
   • Generally given as a single dose before RSV season

---

How the RSV vaccine works

RSV vaccines and monoclonal antibodies target a key viral protein called the “F” (fusion) protein. This protein helps RSV enter human cells. There are two forms of the F protein: prefusion and postfusion. Most new vaccines focus on the prefusion F protein, which triggers the strongest neutralizing-antibody response.

• Prefusion stabilization
  Researchers modify the F protein so it stays in its prefusion shape when injected. This “locks” in the most effective target for the immune system.

• Antibody production
  The immune system sees the stabilized prefusion protein and makes neutralizing antibodies. If real RSV ever shows up, these antibodies bind to the virus and block infection of lung cells.

• Monoclonal antibodies
  Instead of training your body to make its own antibodies, monoclonal antibodies are lab-made and given directly. A single dose can provide immediate protection that lasts through RSV season.

---

Effectiveness and safety

Large clinical trials and real-world data show that RSV vaccines and monoclonal antibodies:

• Reduce severe RSV disease by up to 80–90% in infants and older adults
• Cut hospitalizations significantly in both young and elderly populations
• Show strong safety profiles with most side effects being mild

According to public health authorities, these products have undergone rigorous testing and ongoing monitoring to ensure benefits outweigh risks.

---

Possible side effects

Like any vaccine or injected medicine, RSV vaccines and monoclonal antibodies can cause mild to moderate side effects. The most common include:

• Pain, redness or swelling at the injection site
• Fatigue or muscle aches
• Headache or mild fever
• Rare allergic reactions (health care settings are prepared to manage these)

Serious side effects are very uncommon. If you experience difficulty breathing, swelling of the face or throat, or other severe symptoms, seek medical help immediately.

---

When and how to get the RSV vaccine

• Infants/Young children: Health care providers decide timing based on local RSV season (often fall through spring) and individual risk factors. A single dose of monoclonal antibody is usually given once per RSV season.
• Pregnant people: One dose between weeks 32–36 of each pregnancy is recommended to protect the newborn.
• Adults 60+: A single dose before the start of RSV season. Check with your doctor or local health department for exact timing.

Most RSV vaccines are covered by health insurance, Medicare Part B, or other public health programs. Always confirm coverage and availability with your provider.

---

Next steps and additional resources

• If you or your loved one has symptoms such as persistent cough, wheezing, or difficulty breathing, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to help decide whether to seek medical care.
• Discuss any chronic health issues, allergies, or previous vaccine reactions with your doctor before scheduling an RSV vaccine or monoclonal antibody injection.
• Stay informed about local RSV activity by checking updates from trusted public health agencies (e.g., the Centers for Disease Control and Prevention).

---

Speak to a doctor

This information is based on current data from leading health agencies and clinical trials. It’s not a substitute for professional medical advice. Always speak to a health care provider if you:

• Experience severe or worsening symptoms
• Have questions about vaccine timing, safety or interactions
• Face any potentially life-threatening situation

Protecting yourself and those you love from RSV starts with understanding what is RSV vaccine, making informed choices, and staying in touch with your doctor.